325 Million USD for further development of its cancer immunotherapy. Learn more at: https://biontech.de/2019/07/09/biontech-raises-usd-325-million-in-an-upsized-series-b-financing-to-further-advance-individualized-immuno-oncology-pipeline/
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information